CREPT is required for the metastasis of triple-negative breast cancer through a co-operational-chromatin loop-based gene regulation

  • 0State Key Laboratory of Membrane Biology, School of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, 100084, China.

|

|

Summary

This summary is machine-generated.

CREPT/RPRD1B drives aggressive triple-negative breast cancer (TNBC) metastasis by altering genome structure. Targeting CREPT disrupts these changes, offering a potential therapy for TNBC.

Area Of Science

  • Oncology
  • Molecular Biology
  • Genomics

Background

  • Triple-negative breast cancer (TNBC) is highly aggressive, with metastasis mechanisms poorly understood.
  • Somatic gene copy-number amplifications and elevated expression of CREPT/RPRD1B are observed in TNBC.
  • CREPT/RPRD1B expression correlates with poor patient survival and is implicated in TNBC metastasis.

Purpose Of The Study

  • To investigate the role of CREPT/RPRD1B in TNBC metastasis.
  • To elucidate the molecular mechanisms by which CREPT/RPRD1B promotes metastasis.
  • To evaluate CREPT/RPRD1B as a therapeutic target for metastatic TNBC.

Main Methods

  • Analysis of gene copy-number and expression data in TNBC.
  • Demonstration of CREPT/RPRD1B's effect on three-dimensional genome structure (TADs, chromatin loops).
  • Validation of chromatin loops using HiChIP and Tn5-FISH.
  • CRISPR-dCas9 to disrupt chromatin loops and AAV-based shRNA to deplete CREPT in mouse models.

Main Results

  • CREPT/RPRD1B amplifications and elevated expression are linked to poor TNBC patient survival.
  • CREPT/RPRD1B alters 3D genome organization, mediating 1082 co-operational chromatin loops.
  • These loops enhance metastatic gene expression by orchestrating RNAPII activity.
  • Disrupting these loops or depleting CREPT suppresses TNBC metastasis in vivo.

Conclusions

  • CREPT/RPRD1B is a key driver of TNBC metastasis through 3D genome structural alterations.
  • Targeting CREPT/RPRD1B to disrupt these aberrant chromatin loops presents a novel therapeutic strategy.
  • This approach holds promise for treating patients with metastatic triple-negative breast cancer.

Related Concept Videos

Epigenetic Regulation 01:37

3.0K

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...

Metastasis 02:30

5.5K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

mTOR Signaling and Cancer Progression 03:03

3.8K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Master Transcription Regulators 02:23

6.9K

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...

Chromatin Position Affects Gene Expression 02:35

23.3K

Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences  access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area. 
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...

lncRNA - Long Non-coding RNAs 02:39

8.5K

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...